These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30223346)

  • 1. Response to letter from Drs. Li et al. regarding our paper in Int. J. Cardiol. 2018. Doi: 10.1016/j.ijcard.2017.09.010: SCN5A mutation type and topology are associated with the risk of ventricular arrhythmia by sodium channel blockers.
    Amin AS; Wilde AAM; Tan HL
    Int J Cardiol; 2018 Nov; 271():124. PubMed ID: 30223346
    [No Abstract]   [Full Text] [Related]  

  • 2. SCN5A mutation type and topology are associated with the risk of ventricular arrhythmia by sodium channel blockers.
    Amin AS; Reckman YJ; Arbelo E; Spanjaart AM; Postema PG; Tadros R; Tanck MW; Van den Berg MP; Wilde AAM; Tan HL
    Int J Cardiol; 2018 Sep; 266():128-132. PubMed ID: 29709244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myotonic dystrophy type 1 mimics and exacerbates Brugada phenotype induced by Nav1.5 sodium channel loss-of-function mutation.
    Pambrun T; Mercier A; Chatelier A; Patri S; Schott JJ; Le Scouarnec S; Chahine M; Degand B; Bois P
    Heart Rhythm; 2014 Aug; 11(8):1393-400. PubMed ID: 24768612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventricular arrhythmia during ajmaline challenge for the Brugada syndrome.
    Dobbels B; De Cleen D; Ector J
    Europace; 2016 Oct; 18(10):1501-1506. PubMed ID: 26941343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New risk stratification on SCN5A mutation in Brugada syndrome.
    Li X; Shang H; Xing Y
    Int J Cardiol; 2018 Nov; 271():123. PubMed ID: 30223345
    [No Abstract]   [Full Text] [Related]  

  • 6. Malignant response to ajmaline challenge in SCN5A mutation carriers: experience from a large familial study.
    Gandjbakhch E; Fressart V; Duthoit G; Marquié C; Deharo JC; Pousset F; Hebert JL; Simon F; Himbert C; Klug D; Charron P; Hidden-Lucet F
    Int J Cardiol; 2014 Mar; 172(1):256-8. PubMed ID: 24476701
    [No Abstract]   [Full Text] [Related]  

  • 7. Value of electrocardiographic parameters and ajmaline test in the diagnosis of Brugada syndrome caused by SCN5A mutations.
    Hong K; Brugada J; Oliva A; Berruezo-Sanchez A; Potenza D; Pollevick GD; Guerchicoff A; Matsuo K; Burashnikov E; Dumaine R; Towbin JA; Nesterenko V; Brugada P; Antzelevitch C; Brugada R
    Circulation; 2004 Nov; 110(19):3023-7. PubMed ID: 15520322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual phenotypic transmission in Brugada syndrome.
    Hermida JS; Arnalsteen-Dassonvalle E; Kubala M; Mathiron A; Traulle S; Anbazhagan K; Hermida A; Rochette J
    Arch Cardiovasc Dis; 2013; 106(6-7):366-72. PubMed ID: 23810369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of the sodium-channel blocker challenge in Brugada syndrome.
    Therasse D; Sacher F; Babuty D; Mabo P; Mansourati J; Kyndt F; Redon R; Schott JJ; Barc J; Probst V; Gourraud JB
    Int J Cardiol; 2017 Oct; 245():178-180. PubMed ID: 28784436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium channel blocker challenge in Brugada syndrome: Role in risk stratification.
    Therasse D; Probst V; Gourraud JB
    Int J Cardiol; 2018 Aug; 264():100-101. PubMed ID: 29776556
    [No Abstract]   [Full Text] [Related]  

  • 11. Variants in the SCN5A Promoter Associated With Various Arrhythmia Phenotypes.
    Yagihara N; Watanabe H; Barnett P; Duboscq-Bidot L; Thomas AC; Yang P; Ohno S; Hasegawa K; Kuwano R; Chatel S; Redon R; Schott JJ; Probst V; Koopmann TT; Bezzina CR; Wilde AA; Nakano Y; Aiba T; Miyamoto Y; Kamakura S; Darbar D; Donahue BS; Shigemizu D; Tanaka T; Tsunoda T; Suda M; Sato A; Minamino T; Endo N; Shimizu W; Horie M; Roden DM; Makita N
    J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27625342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yield and Pitfalls of Ajmaline Testing in the Evaluation of Unexplained Cardiac Arrest and Sudden Unexplained Death: Single-Center Experience With 482 Families.
    Tadros R; Nannenberg EA; Lieve KV; Škorić-Milosavljević D; Lahrouchi N; Lekanne Deprez RH; Vendrik J; Reckman YJ; Postema PG; Amin AS; Bezzina CR; Wilde AAM; Tan HL
    JACC Clin Electrophysiol; 2017 Dec; 3(12):1400-1408. PubMed ID: 29759671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response by Yamagata et al to Letter Regarding Article, "Genotype-Phenotype Correlation of
    Yamagata K; Aiba T; Shimizu W
    Circulation; 2017 Dec; 136(23):2289-2290. PubMed ID: 29203570
    [No Abstract]   [Full Text] [Related]  

  • 14. A second case with arrhythmogenic cardiomyopathy, provocable Brugada ECG and SCN5A mutation.
    S P
    Int J Cardiol; 2014 Feb; 171(3):e117-8. PubMed ID: 24388542
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanism of right precordial ST-segment elevation in structural heart disease: excitation failure by current-to-load mismatch.
    Hoogendijk MG; Potse M; Linnenbank AC; Verkerk AO; den Ruijter HM; van Amersfoorth SC; Klaver EC; Beekman L; Bezzina CR; Postema PG; Tan HL; Reimer AG; van der Wal AC; Ten Harkel AD; Dalinghaus M; Vinet A; Wilde AA; de Bakker JM; Coronel R
    Heart Rhythm; 2010; 7(2):238-48. PubMed ID: 20022821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of concealed Brugada syndrome in patients with atrioventricular nodal reentrant tachycardia.
    Hasdemir C; Payzin S; Kocabas U; Sahin H; Yildirim N; Alp A; Aydin M; Pfeiffer R; Burashnikov E; Wu Y; Antzelevitch C
    Heart Rhythm; 2015 Jul; 12(7):1584-94. PubMed ID: 25998140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [SCN5A mutation in patients with Brugada electrocardiographic pattern induced by fever].
    Yu JH; Hu JZ; Zhou H; Liu X; Cao Q; Shen Y; Ma JY; Zhou SZ; Liu XX; Li JX; Chen Q; Cheng XS; Hong K
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Dec; 41(12):1010-4. PubMed ID: 24524602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel SCN5A Mutation Associated with Drug Induced Brugada Type ECG.
    Turker I; Makiyama T; Vatta M; Itoh H; Ueyama T; Shimizu A; Ai T; Horie M
    PLoS One; 2016; 11(8):e0161872. PubMed ID: 27560382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of cardiac sodium channel mutations on initiation of ventricular arrhythmias in patients with Brugada syndrome.
    Morita H; Nagase S; Miura D; Miura A; Hiramatsu S; Tada T; Murakami M; Nishii N; Nakamura K; Morita ST; Oka T; Kusano KF; Ohe T
    Heart Rhythm; 2009 Apr; 6(4):487-92. PubMed ID: 19324308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brugada syndrome: clinical presentation and genotype-correlation with magnetic resonance imaging parameters.
    Rudic B; Schimpf R; Veltmann C; Doesch C; Tülümen E; Schoenberg SO; Borggrefe M; Papavassiliu T
    Europace; 2016 Sep; 18(9):1411-9. PubMed ID: 26511399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.